215 related articles for article (PubMed ID: 26371038)
1. Involvement of the Niacin Receptor GPR109a in the LocalControl of Glucose Uptake in Small Intestine of Type 2Diabetic Mice.
Wong TP; Chan LK; Leung PS
Nutrients; 2015 Sep; 7(9):7543-61. PubMed ID: 26371038
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of ACE2-ANG-(1-7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: implications for glucose transport.
Wong TP; Ho KY; Ng EK; Debnam ES; Leung PS
Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E669-81. PubMed ID: 22811473
[TBL] [Abstract][Full Text] [Related]
3. GPR109A Expression in the Murine Min6 Pancreatic Beta Cell Line, and Its Relation with Glucose Metabolism and Inflammation.
Yang S; Li X; Wang N; Yin G; Ma S; Fu Y; Wei C; Chen Y; Xu W
Ann Clin Lab Sci; 2015; 45(3):315-22. PubMed ID: 26116596
[TBL] [Abstract][Full Text] [Related]
4. Involvement of an enterocyte renin-angiotensin system in the local control of SGLT1-dependent glucose uptake across the rat small intestinal brush border membrane.
Wong TP; Debnam ES; Leung PS
J Physiol; 2007 Oct; 584(Pt 2):613-23. PubMed ID: 17702818
[TBL] [Abstract][Full Text] [Related]
5. The expression of GPR109A, NF-kB and IL-1β in peripheral blood leukocytes from patients with type 2 diabetes.
Liu F; Fu Y; Wei C; Chen Y; Ma S; Xu W
Ann Clin Lab Sci; 2014; 44(4):443-8. PubMed ID: 25361930
[TBL] [Abstract][Full Text] [Related]
6. Niacin receptor GPR109A inhibits insulin secretion and is down-regulated in type 2 diabetic islet beta-cells.
Wang N; Guo DY; Tian X; Lin HP; Li YP; Chen SJ; Fu YC; Xu WC; Wei CJ
Gen Comp Endocrinol; 2016 Oct; 237():98-108. PubMed ID: 27570060
[TBL] [Abstract][Full Text] [Related]
7. Niacin stimulates adiponectin secretion through the GPR109A receptor.
Plaisance EP; Lukasova M; Offermanns S; Zhang Y; Cao G; Judd RL
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E549-58. PubMed ID: 19141678
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus and expression of the enterocyte renin-angiotensin system: implications for control of glucose transport across the brush border membrane.
Wong TP; Debnam ES; Leung PS
Am J Physiol Cell Physiol; 2009 Sep; 297(3):C601-10. PubMed ID: 19535516
[TBL] [Abstract][Full Text] [Related]
9. Na
Chan LKY; Wang Y; Ng EKW; Leung PS
Diabetes Obes Metab; 2018 Mar; 20(3):709-717. PubMed ID: 29110392
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Metformin on the Expression of GPR109A, NF-κB and IL-1β in Peripheral Blood Leukocytes from Patients with Type 2 Diabetes Mellitus.
Xu X; Lin S; Chen Y; Li X; Ma S; Fu Y; Wei C; Wang C; Xu W
Ann Clin Lab Sci; 2017 Sep; 47(5):556-562. PubMed ID: 29066482
[TBL] [Abstract][Full Text] [Related]
11. Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets.
Chen L; So WY; Li SY; Cheng Q; Boucher BJ; Leung PS
Mol Cell Endocrinol; 2015 Mar; 404():56-66. PubMed ID: 25622782
[TBL] [Abstract][Full Text] [Related]
12. A novel treatment target for Parkinson's disease.
Wakade C; Chong R
J Neurol Sci; 2014 Dec; 347(1-2):34-8. PubMed ID: 25455298
[TBL] [Abstract][Full Text] [Related]
13. GSK256073, a selective agonist of G-protein coupled receptor 109A (GPR109A) reduces serum glucose in subjects with type 2 diabetes mellitus.
Dobbins RL; Shearn SP; Byerly RL; Gao FF; Mahar KM; Napolitano A; Nachbaur GJ; Le Monnier de Gouville AC
Diabetes Obes Metab; 2013 Nov; 15(11):1013-21. PubMed ID: 23701262
[TBL] [Abstract][Full Text] [Related]
14. Future of GPR109A agonists in the treatment of dyslipidaemia.
Wanders D; Judd RL
Diabetes Obes Metab; 2011 Aug; 13(8):685-91. PubMed ID: 21418500
[TBL] [Abstract][Full Text] [Related]
15. Langerhans cells release prostaglandin D2 in response to nicotinic acid.
Maciejewski-Lenoir D; Richman JG; Hakak Y; Gaidarov I; Behan DP; Connolly DT
J Invest Dermatol; 2006 Dec; 126(12):2637-46. PubMed ID: 17008871
[TBL] [Abstract][Full Text] [Related]
16. The Role of GPR109a Signaling in Niacin Induced Effects on Fed and Fasted Hepatic Metabolism.
Geisler CE; Miller KE; Ghimire S; Renquist BJ
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924461
[TBL] [Abstract][Full Text] [Related]
17. GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy.
Gambhir D; Ananth S; Veeranan-Karmegam R; Elangovan S; Hester S; Jennings E; Offermanns S; Nussbaum JJ; Smith SB; Thangaraju M; Ganapathy V; Martin PM
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2208-17. PubMed ID: 22427566
[TBL] [Abstract][Full Text] [Related]
18. Nicotinic Acid Receptor GPR109A Exerts Anti-Inflammatory Effects Through Inhibiting the Akt/mTOR Signaling Pathway in MIN6 Pancreatic β cells.
Li Z; Li X; Lin S; Chen Y; Ma S; Fu Y; Wei C; Xu W
Ann Clin Lab Sci; 2017 Nov; 47(6):729-737. PubMed ID: 29263047
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids enhance intestinal glucose uptake via the dimerized glucocorticoid receptor in enterocytes.
Reichardt SD; Föller M; Rexhepaj R; Pathare G; Minnich K; Tuckermann JP; Lang F; Reichardt HM
Endocrinology; 2012 Apr; 153(4):1783-94. PubMed ID: 22294744
[TBL] [Abstract][Full Text] [Related]
20. Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression.
Lauring B; Taggart AK; Tata JR; Dunbar R; Caro L; Cheng K; Chin J; Colletti SL; Cote J; Khalilieh S; Liu J; Luo WL; Maclean AA; Peterson LB; Polis AB; Sirah W; Wu TJ; Liu X; Jin L; Wu K; Boatman PD; Semple G; Behan DP; Connolly DT; Lai E; Wagner JA; Wright SD; Cuffie C; Mitchel YB; Rader DJ; Paolini JF; Waters MG; Plump A
Sci Transl Med; 2012 Aug; 4(148):148ra115. PubMed ID: 22914621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
